9606.HK
Price:
$336
Market Cap:
$26.87B
Duality Biotherapeutics, Inc. operates as a clinical stage company. It focuses on the development of next generation antibody-drug conjugate therapeutics and duality immune toxin antibody conjugate therapeutic. The company was founded by Zhu Zhong Yuan on July 3, 2019 and is headquartered in Shanghai, China.
Industry
Biotechnology
IPO Date
2025-04-15
Stock Exchange
HKSE
Ticker
9606.HK
According to Duality Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -9.49. This represents a change of 207.01% compared to the average of -3.09 of the last 4 quarters.
The mean historical PE Ratio of Duality Biotherapeutics, Inc. over the last ten years is -32.45. The current -9.49 PE Ratio has changed 2.82% with respect to the historical average. Over the past ten years (40 quarters), 9606.HK's PE Ratio was at its highest in in the September 2024 quarter at 0. The PE Ratio was at its lowest in in the December 2023 quarter at -15.85.
Average
-32.45
Median
-38.90
Minimum
-43.22
Maximum
-15.25
Discovering the peaks and valleys of Duality Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.11%
Maximum Annual PE Ratio = -15.25
Minimum Annual Increase = -64.72%
Minimum Annual PE Ratio = -43.22
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -15.25 | -64.72% |
| 2023 | -43.22 | 11.11% |
The current PE Ratio of Duality Biotherapeutics, Inc. (9606.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-32.45
5-year avg
-32.45
10-year avg
-32.45
Duality Biotherapeutics, Inc.’s PE Ratio is greater than Zai Lab Limited (-10.30), greater than Ascentage Pharma Group International (-17.00), less than Simcere Pharmaceutical Group Limited (34.02), less than Asymchem Laboratories (Tianjin) Co., Ltd. (31.51), less than The United Laboratories International Holdings Limited (6.96), greater than InnoCare Pharma Limited (-75.70), less than Shandong Weigao Group Medical Polymer Company Limited (11.68), less than Grand Pharmaceutical Group Limited (13.74), greater than Everest Medicines Limited (-20.37), greater than MicroPort Scientific Corporation (-14.47),
| Company | PE Ratio | Market cap |
|---|---|---|
| -10.30 | $17.28B | |
| -17.00 | $23.63B | |
| 34.02 | $33.17B | |
| 31.51 | $28.58B | |
| 6.96 | $25.49B | |
| -75.70 | $21.45B | |
| 11.68 | $24.73B | |
| 13.74 | $28.57B | |
| -20.37 | $16.04B | |
| -14.47 | $20.64B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Duality Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Duality Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Duality Biotherapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Duality Biotherapeutics, Inc. (9606.HK)?
What is the highest PE Ratio for Duality Biotherapeutics, Inc. (9606.HK)?
What is the 3-year average PE Ratio for Duality Biotherapeutics, Inc. (9606.HK)?
What is the 5-year average PE Ratio for Duality Biotherapeutics, Inc. (9606.HK)?
How does the current PE Ratio for Duality Biotherapeutics, Inc. (9606.HK) compare to its historical average?